Analysts who follow Terns Pharmaceuticals Inc (TERN) on average expect it to gain 12.02% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns the stock an Analyst Ranking of 23, which means it ranks higher than 23 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating TERN a Buy today. Find out what this means to you and get the rest of the rankings on TERN!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Terns Pharmaceuticals Inc Stock Today?
Terns Pharmaceuticals Inc (TERN) stock is trading at $4.91 as of 3:27 PM on Thursday, Sep 22, a drop of -$0.75, or -13.21% from the previous closing price of $5.66. The stock has traded between $4.85 and $5.65 so far today. Volume today is light. So far 154,409 shares have traded compared to average volume of 713,718 shares.
Click Here to get the full Stock Report for Terns Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
